Glycemics Flashcards

1
Q

SULFONYLUREAS

Example
Indications
Mechanism of action
Side Effects
Contraindication/considerations
A

E- 2nd Gen- glyburide, glipizide, glimeperide [IDES]

I- DM2, fasting and postprandial

M- enhance insulin secretion by blocking ATP-sensitive K+ channels in cell membranes of pancreatic cells [pancreas] / Hepatic metabolize (CYP 450 2C9), renal excretion

S- hypoglycemia & weight gain; avoid alcohol

C- elderly patients (renal/hepatic) - lower dose

  • *only tolbutamide requires dosage adjust
  • inability to stimulate insulin release at extremely high glucose levels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
NONSULFONYLRUEA SECRATGOGUES

Example
Indications
Mechanism of action
Side Effects
Contraindication/considerations
A

E- glinides / meglitinides

I- DM 2, reduce post meal glucose levels

M- very similar to sulfonylureas, but shorter onset and duration; 15 minutes before meal

S- hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

BIGUANIDES

Example
Indications
Mechanism of action
Side Effects
Contraindication/considerations
A

E- metformin; 500mg BID

I- DM 2, fasting and postprandial

M- decrease hepatic glucose production and increase insulin sensitivity in both hepatic and peripheral muscle tissue

S-GI (appetite, nausea, and diarrhea), b12 absorption

C- eGFR < 30; hold 24 hours before surgery; radiographic procedure; lactic acidosis

FIRST LINE therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

THIAZOLIDINEDIONES (TZDs)
[great for cardio / fat but risky s/e]

Example
Indications
Mechanism of action
Side Effects
Contraindication/considerations
A

E- pioglitazone, rosiglitazone (-litazones)
– 15-30mg/day, increase up to 45 after 12 weeks (how long it takes to effect)

I- DM 2, Fasting and postprandial

M- increase insulin sensitivity by stimulating PPAR-Y

S- onset delayed several weeks (12 weeks); fluid retention and edema; weight gain, fractures, bladder CA

C- Heart Failure; piggy better for heart, rosi bad; monitor liver enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ALPHA-GLUCOSIDASE INHIBITORS

Example
Indications
Mechanism of action
Side Effects
Contraindication/considerations
A

E- Acarbose; miglitol
–25mg TID w/ meals; advance 4-8 week intervals up to 100mg TID

I- DM 2, postprandial

M- small intestine, delay absorption; post prandial

S- GI – farts, abd discomfort, diarrhea

C- intestinal disease; high serum creatinine (> 2mg/dL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DPP-4 INHIBITORS

Example
Indications
Mechanism of action
Side Effects
Contraindication/considerations
A

E- [GLIPTINS] sitagliptin, saxagliptin, linagliptin etc.

I- DM2; primarily post prandial
[GI TRACT]
M- w/ diet and exercise; inhibit DPP-4, which breaks down GLP-1 - more endogenous GLP-1 when eating

S-headache and nasopharyngitis (NOT Hypogly - indirect); pancreatitis

C- once daily med, reduce w/ renal impair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SGLT2 INHIBITORS

Example
Indications
Mechanism of action
Side Effects
Contraindication/considerations
A

E- (-glifozin); canagliflozin, dapagliflozin, empagliflozin

I- DM 2 [KIDNEY], fasting and postprandial

M-inhibition of SGLT2 in proximal tubules, reducing reabsorption of filtered glucose and lowers renal threshold for glucose which together cause increased urinary excretion of glucose and decreased plasma glucose

S- amputation? UTI and genital mycotic infxn; hypotension from osmotic diuresis; fractures and bladder CA; hyperkalemia, DKA**

C- good for cardiovascular; *monitor fluid volume status; ketoacidosis assessment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

CENTRAL ACTING DOPAMINE ANTAGONIST

Example
Indications
Mechanism of action
Side Effects
Contraindication/considerations
A

E- Bromocriptine

I- DM 2, hypothalamus, Postprandial

M- improves insulin sensitivity

S- rhinitis, dizziness, asthenia, H/a, sinusitis, constipation, nausea

C- take 2 hours after waking in AM w/ food
contra- syncopal migraine and nursing women
CyP 34A inhibitor *** (fungals and HIV Meds - dont take; decrease for moderate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BILE ACID SEQUESTRANTS

Example
Indications
Mechanism of action
Side Effects
Contraindication/considerations
A

E- Colesevelam (adjunctive), 1.875g BID

I- DM 2, fasting

M- binds bile acid in intestine

S- constipation and dyspepsia; fat soluble malabsorption

C- Drug-drug interactions r/t absorption (levo, glyburide, contraceptive, phenytoin, warfarin, digoxin; separate 4 hours from pills

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
INSULIN
Regular (short-acting)
Type
Onset
Peak
Duration
Administration
A

“Bolus”; Regular (humulin, Novolin)

Onset - 30 minutes

Peak- 2-3 hours

Duration- 3-6 hours

Administration - IV or SQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
INSULIN
Regular (short-acting)
Type
Onset
Peak
Duration
Administration
A

“Bolus”, Lispro, Aspart, Glulisin

Onset - 15-30 mins

Peak- ~1-3 hours

Duration - 3-4 hours

Administration- IV, SQ, (INH?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

INSULIN
Intermediate Acting

Type
Onset
Peak
Duration
Administration
A

“BASAL”, NPH

Onset - 2-4 hours

Peak- 4-6

Duration 8-12

Administration - SQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

INSULIN
Long-Acting

Type
Onset
Peak
Duration
Administration
A

“BASAL”, Glargine, Detemir, Degludec

Onset- 4-5 hours, no peak, 22-42 hours (Degludec longest)

SQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Combination Therapy

A

NPH and Regular
NPH and lispro
NPH and humalog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Insulin Pump Rules

Required dose vs correction

A
REQUIRED
500 Rule (rapid-acting)
450 Rule (regular insulin)
--> divide 500 by daily dose of insulin
\_\_\_\_\_\_
CORRECTION
1800 rapid, 1500 regular
--> 1800 by total daily insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GLP-1 Agonist

A

Exnatide, Liraglutide, Abligutide, Dulaglutide, Lixisenatide

  • Stimulates insulin release
  • Delays gastric emptying
  • Suppression of postpradial glucagon release

Weight Loss, RENAL adjust for exenatide and lixisenatide (CrCl <15 and 30); others = no adjust

S/E: Acute pancreatitis, GI Side effects

17
Q

pramlintide

A

Synthetic Amylin
slows gastric emptying

S/e: hypoglycemia, n/v, delay of oral meds

18
Q

EFFICIENCY
High
Low

A

HIGH–> biguanide, Sulfonyl, GLP-1 Agonist, TZD

Low –> Dopamine agonist, pramlintie, bile acid

19
Q

Goals for Glycemic Control

1) A1C
2) Fasting Glucose
3) Peak postprandial glucose (1-2 hrs after meal)
4) BP

A

1) <6.5-7.0%
2) 80-130
3) <180
4) 130/80